Cargando…
Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants
This study describes the maturation of sirolimus clearance in a cohort of very young pediatric patients with vascular anomalies. The relationship between allometrically scaled in vivo clearance and age was described by the E(max) model in patients aged 1 month to 2 years. Consistent with the observe...
Autores principales: | Emoto, C, Fukuda, T, Johnson, TN, Adams, DM, Vinks, AA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360665/ https://www.ncbi.nlm.nih.gov/pubmed/26225230 http://dx.doi.org/10.1002/psp4.17 |
Ejemplares similares
-
Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants
por: Emoto, C, et al.
Publicado: (2016) -
Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A Content
por: Emoto, C, et al.
Publicado: (2013) -
Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter
por: Emoto, C, et al.
Publicado: (2016) -
A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition
por: Emoto, Chie, et al.
Publicado: (2019) -
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
por: Emoto, Chie, et al.
Publicado: (2018)